Literature DB >> 2452989

Positive inotropic effects of the calcium channel activator Bay K 8644 on guinea-pig and human isolated myocardium.

M Näbauer1, L Brown, E Erdmann.   

Abstract

1. The positive inotropic effects of the dihydropyridine calcium activator Bay K 8644 were studied in guinea-pig isolated contracting myocardium and human papillary muscle strips obtained from patients undergoing mitral valve replacement or cardiac transplantation. 2. Bay K 8644 produced a slowly developing, concentration-dependent positive inotropic response in all cardiac tissues studied. In guinea-pig papillary muscle, the increase in force of contraction was half-maximal at 3.9 x 10(-8) mol/l and the maximal inotropic effect was comparable to that obtained with ouabain, dobutamine or calcium. The guinea-pig left atrium (EC50, 2.1 x 10(-7) mol/l) was fivefold less sensitive than the papillary muscle. 3. The maximal inotropic response to dihydroouabain was significantly increased after preincubation with Bay K 8644 (1 x 10(-6) mol/l) in papillary muscles from both guinea-pig and human. In guinea-pig papillary muscles, the maximal inotropic response to dobutamine was not changed by preincubation with Bay K 8644 whereas in human papillary muscle strips, Bay K 8644 increased the inotropic response to dobutamine. 4. Bay K 8644 increased force of contraction (EC50, 4 x 10(-8) mol/l) in human papillary muscle strips from patients undergoing mitral valve replacement. However, the maximal inotropic response to Bay K 8644 was reduced to 32 +/- 4.4% that of calcium (15 mmol/l) measured in the same muscle strips. 5. A further reduction in maximal inotropic response to Bay K 8644 to 13 +/- 1.2% that of calcium (15 mmol/l) with no change in potency was measured in human papillary muscle strips taken from terminally failing hearts of cardiac transplant recipients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452989     DOI: 10.1007/bf00169482

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  45 in total

1.  Profile of the oppositely acting enantiomers of the dihydropyridine 202-791 in cardiac preparations: receptor binding, electrophysiological, and pharmacological studies.

Authors:  J S Williams; I L Grupp; G Grupp; P L Vaghy; L Dumont; A Schwartz; A Yatani; S Hamilton; A M Brown
Journal:  Biochem Biophys Res Commun       Date:  1985-08-30       Impact factor: 3.575

Review 2.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

3.  "Supramaximal" enhancement of the inotropic effect of noradrenaline by tyramine.

Authors:  W Brandt; M Reiter; K Seibel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  Ionic events responsible for the cardiac resting and action potential.

Authors:  M Morad; L Tung
Journal:  Am J Cardiol       Date:  1982-02-18       Impact factor: 2.778

5.  Beta-adrenergic modulation of calcium channels in frog ventricular heart cells.

Authors:  B P Bean; M C Nowycky; R W Tsien
Journal:  Nature       Date:  1984 Jan 26-Feb 1       Impact factor: 49.962

6.  The positive inotropic dihydropyridine Bay K 8644 does not affect calcium sensitivity or calcium release of skinned cardiac fibres.

Authors:  G Thomas; R Gross; G Pfitzer; J C Rüegg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

7.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

8.  Effects of in vivo beta-adrenoceptor down-regulation on cardiac responses to prenalterol and pirbuterol.

Authors:  T P Kenakin; R M Ferris
Journal:  J Cardiovasc Pharmacol       Date:  1983 Jan-Feb       Impact factor: 3.105

Review 9.  Inotropic drugs and their mechanisms of action.

Authors:  H Scholz
Journal:  J Am Coll Cardiol       Date:  1984-08       Impact factor: 24.094

10.  Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells.

Authors:  S Kokubun; H Reuter
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

View more
  5 in total

1.  Reduced effects of BAY K 8644 on L-type Ca2+ current in failing human cardiac myocytes are related to abnormal adrenergic regulation.

Authors:  Xiongwen Chen; Xiaoying Zhang; David M Harris; Valentino Piacentino; Remus M Berretta; Kenneth B Margulies; Steven R Houser
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-03-21       Impact factor: 4.733

2.  Positive chronotropic effect of Bay K 8644: participation of endogenous norepinephrine.

Authors:  M C de Hurtado; O A Gende; H E Cingolani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

3.  Comparison between the cardiac effects induced by muzolimine and furosemide in guinea-pig atria.

Authors:  P Dorigo; R M Gaion; M Bergamin; A Giacometti; E Valentini; I Maragno
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

4.  Positive inotropic stimulation in the normal and insufficient human myocardium.

Authors:  E Erdmann; M Böhm
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

5.  Comparison of calcium-current in isolated atrial myocytes from failing and nonfailing human hearts.

Authors:  T H Cheng; F Y Lee; J Wei; C I Lin
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.